COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

COVID-19 Briefings

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

New COVID-19 Travel Testing Order Set to Go into Effect Jan. 26

CDC orders airlines to verify and confirm documentation for SARS-CoV-2 COVID-19 negative test
Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on whatsapp
Share on email
Share on facebook
Share on twitter
Share on linkedin
Share on google
Share on whatsapp
Share on email

CDC issues new guidance requiring all international travelers flying into the US to have a negative COVID-19 test

The US Centers for Disease Control and Prevention (CDC) announced Jan. 15, 2021, that all travelers flying into the United States from an international destination will be required to have a negative COVID-19 test result. These test results must be obtained within three days before departing.

The CDC does make some exceptions for this new requirement. Children under the age of 2 years old and those who have tested positive for SARS-CoV-2 within the last three months, and have met the requirements to end isolation, may travel without a negative test result.

Proof of a negative result using either molecular or antigen testing is sufficient to prove one’s COVID-19 negative status. The CDC holds the airlines responsible for verifying their passengers’ COVID-19 test status.

This new order is set to go into effect on Jan. 26, 2021, and expands on a previous CDC requirement that applied only to travel originating in the United Kingdom (See CDC Announces New Testing Requirement for Travelers Arriving from the UK).

Clinical laboratory directors wishing to review the CDC’s new requirement (for all airline or other aircraft passengers into the United States from any foreign country) in its entirety can do so here.

Related Resources:


Helping Your Lab Stay Afloat During Challenging Times

Dear Colleague,

Robert L. MichelIn these challenging times for our colleagues in clinical laboratories, pathology practices and hospital administration, The Dark Intelligence Group (TDIG) — through generous grants from our partners — is bringing you the COVID-19 STAT Intelligence Briefings.

We’ve added analysts, writers and skilled editors to the COVID-19 STAT team to uncover, analyze, and immediately report to you what’s happening with the SARS-CoV-2 pandemic, packaged with the insights you need to deliver quality testing for patient care and keep your lab’s financial ship afloat. As part of our mission, we are also bringing you real-time data from our partners around testing that you will not find anywhere else.

Please let me know how we can better improve this service to fit your needs. If you would like to offer a grant to keep our mission going with this site, please contact me at


Robert L. Michel
President, Founder
The Dark Intelligence Group